You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Harvard Business School
McKinsey
AstraZeneca
Mallinckrodt

Last Updated: June 3, 2020

DrugPatentWatch Database Preview

Patent: 8,343,950

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,343,950
Title:Quinazoline derivatives and methods of treatment
Abstract: This invention relates to novel quinazoline derivatives, and their pharmaceutically acceptable salts. The invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions beneficially treated by inhibiting cell surface tyrosine receptor kinases.
Inventor(s): Tung; Roger (Lexington, MA)
Assignee: Concert Pharmaceuticals, Inc. (Lexington, MA)
Application Number:11/957,442
Patent Claims:see list of patent claims

Details for Patent 8,343,950

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25   Start Trial Concert Pharmaceuticals, Inc. (Lexington, MA) 2026-12-15 RX Orphan search
Amgen NEULASTA pegfilgrastim SYRINGE 125031 001 2002-01-31   Start Trial Concert Pharmaceuticals, Inc. (Lexington, MA) 2026-12-15 RX Orphan search
Imclone ERBITUX cetuximab VIAL; INTRAVENOUS 125084 001 2004-06-18   Start Trial Concert Pharmaceuticals, Inc. (Lexington, MA) 2026-12-15 RX Orphan search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26   Start Trial Concert Pharmaceuticals, Inc. (Lexington, MA) 2026-12-15 RX Orphan search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26   Start Trial Concert Pharmaceuticals, Inc. (Lexington, MA) 2026-12-15 RX Orphan search
Amgen VECTIBIX panitumumab INJECTABLE; IV (INFUSION) 125147 001 2006-09-27   Start Trial Concert Pharmaceuticals, Inc. (Lexington, MA) 2026-12-15 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Johnson and Johnson
Baxter
Colorcon
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.